Grasiele S.V. Tavares

A candidate vaccine for human visceral leishmaniasis based on a specific T cell epitope-containing chimeric protein protects mice against Leishmania infantum infection

Daniela P. Lage, Patrícia A.F. Ribeiro, Daniel Dias et al. · npj Vaccines · 2020 · 47 citations · Full text

Antileishmanial activity and mechanism of action from a purified fraction of Zingiber officinalis Roscoe against Leishmania amazonensis

Mariana C. Duarte, Grasiele S.V. Tavares, Diogo G. Valadares et al. · Experimental Parasitology · 2016 · 45 citations

Antileishmanial Activity, Antiparasitic Agent, Medicine +9

In vivo antileishmanial efficacy of a naphthoquinone derivate incorporated into a Pluronic® F127-based polymeric micelle system against Leishmania amazonensis infection

Débora V.C. Mendonça, Grasiele S.V. Tavares, Daniela P. Lage et al. · Biomedicine & Pharmacotherapy · 2018 · 31 citations · Full text

A clioquinol-containing Pluronic^® F127 polymeric micelle system is effective in the treatment of visceral leishmaniasis in a murine model

Grasiele S.V. Tavares, Débora V.C. Mendonça, Isabela A.G. Pereira et al. · Parasite · 2020 · 30 citations · Full text

A Pluronic® F127-based polymeric micelle system containing an antileishmanial molecule is immunotherapeutic and effective in the treatment against Leishmania amazonensis infection

Grasiele S.V. Tavares, Débora V.C. Mendonça, Carolina K. Miyazaki et al. · Parasitology International · 2018 · 29 citations

Antileishmanial Molecule, Antiparasitic Agent, Medicine +7